Abstract 1633: ABL501, PD-L1 X LAG-3, a Bispecific Antibody Promotes Enhanced Human T Cell Activation Through Targeting Simultaneously Two Immune Checkpoint Inhibitors, LAG-3 and PD-L1
Cancer Research（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要